FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreHHS issued an enforcement alert Sept. 4, reminding actors — which includes healthcare providers, health information networks or exchanges and developers of certified health IT — that information blocking rules remain in effect and investigation-confirmed violations will be penalized. The alert does not revise HHS’ current regulations or guidance.
Information blocking by a healthcare provider means the actor knows a given practice is unreasonable and likely to interfere with, prevent, or materially discourage access, exchange, or use of electronic health information (EHI). Providers are subject to disincentives for violating information blocking rules.
The ACR® Information Blocking webpage provides radiology-relevant information, FAQs and links to HHS resources.
For more information or questions about ACR’s related advocacy for data sharing and interoperability, contact Michael Peters, ACR Senior Director, Government Affairs.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more